(Q74569715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

3

Pekka Hellström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Eero Kaasinen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Erkki Rintala

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Jouko Viitanen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Harri Juusela

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Pertti Rajala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Heikki Korhonen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Tapani Liukkonen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

FinnBladder Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

167-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

The management of superficial bladder cancer

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Factors affecting recurrence and progression in superficial bladder tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary ca

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Wor

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-alpha2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

A controlled trial of single dose intravesical adriamycin in superficial bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Urothelial susceptibility to tumor cell implantation: influence of cauterization

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

Adjuvant Chemotherapy of Recurrent Superficial Transitional Cell Carcinoma: Results of a European Organization for Research on Treatment of Cancer Randomized Trial Comparing Intravesical Instillation of Thiotepa, Doxorubicin and Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900260-9

7 January 2021

10.1016/S0302-2838(02)00260-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12160589%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference